Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Aimmune Therapeutics, Inc. (AIMT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/23/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of AIMT, BMCH, BYFC, and CGIX Mergers |
08/31/2020 |
GN
| AIMMUNE THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AIMT and Encourages Investors to Contact the Firm |
03/05/2019 |
GN
| Detailed Research: Economic Perspectives on Canopy Growth, Aimmune Therapeutics, Nektar Therapeutics, Workday, Workiva, and MAG Silver — What Drives Growth in Today's Competitive Landscape |
11/28/2018 |
GN
| Market Trends Toward New Normal in Genomic Health, Beacon Roofing Supply, Cronos Group, Aimmune Therapeutics, OGE Energy, and Spartan Motors — Emerging Consolidated Expectations, Analyst Ratings |
08/23/2018 |
GN
| Report: Developing Opportunities within Aimmune Therapeutics, Everbridge, Roku, Bristow Group, Atlas Air Worldwide, and Edgewell Personal Care — Future Expectations, Projections Moving into 2018 |
06/15/2018 |
GN
| New Research Coverage Highlights Avery Dennison, Raymond James Financial, Genuine Parts, Kimco Realty, Bristow Group, and Aimmune Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018 |
05/09/2018 |
BW
| Aimmune Therapeutics to Participate in Four Upcoming Investor Conferences in May and June |
05/08/2018 |
BW
| Aimmune Therapeutics Announces First Quarter 2018 Financial Results |
04/19/2018 |
GN
| Market Trends Toward New Normal in Genuine Parts, Energizer, Arthur J. Gallagher, Aimmune Therapeutics, Roku, and Premier — Emerging Consolidated Expectations, Analyst Ratings |
03/12/2018 |
BW
| Aimmune Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results |
02/26/2018 |
BW
| Aimmune Therapeutics Announces Closing of Public Offering of Common Stock |
02/08/2018 |
GN
| Report: Exploring Fundamental Drivers Behind Stericycle, Hemisphere Media Group, Expedia, Olin, Aimmune Therapeutics, and Waste Management — New Horizons, Emerging Trends, and Upcoming Developments |
01/03/2018 |
BW
| Aimmune Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference |
11/20/2017 |
BW
| Aimmune Therapeutics to Host Investor Symposium on Peanut Allergy Treatment with Leading Expert Allergists on Friday, December 1 |
|
|